The case for banning heritable genome editing

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Lander E, Baylis F, Zhang F, et al. Adopt a moratorium on heritable genome editing. Nature. 2019;567:165–168.

  2. 2.

    Wolinetz CD, Collins FS. NIH supports call for moratorium on clinical uses of germline gene editing. Nature. 2019;567:175.

  3. 3.

    Rosenbaum L. the future of gene editing—toward scientific and social consensus. N Engl J Med. 2019;380:971–975.

  4. 4.

    Brokowski C. Do CRISPR germline ethics statements cut it? CRISPR J. 2018;1:115–125.

  5. 5.

    ACMG Board of Directors. Genome editing in clinical genetics: points to consider—a statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:723–724.

  6. 6.

    Lander E. Brave new genome. N Engl J Med. 2015;373:5–7.

  7. 7.

    Cystic Fibrosis Foundation. Patient Registry annual data report 2017. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2017-Patient-Registry-Annual-Data-Report.pdf. Accessed 6 September 2019.

  8. 8.

    Gardner K, Douiri A, Drasar E, Allman M, Mwirigi A, Awogbade M, Thein SL. Survival in adults with sickle cell disease in a high-income setting. Blood. 2016;128:1436–1438.

  9. 9.

    National Academies of Sciences, Engineering, and Medicine. Human genome editing: science, ethics, and governance. Washington, DC: National Academies Press; 2017.

  10. 10.

    Johnston J, Zacharias RL. Chapter 75: US stem cell research policy. In: Atala A, Lanza R, Mikos AG, Nerem R, editors. Principles of regenerative medicine. 2019. p. 1309–1329.

Download references

Author information

Correspondence to Jeffrey R. Botkin MD, MPH.

Ethics declarations

Disclosure

J.R.B. declares no conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Botkin, J.R. The case for banning heritable genome editing. Genet Med (2019). https://doi.org/10.1038/s41436-019-0696-6

Download citation